Anna Eichenberger

Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

Benjamin Speich, Frédérique Chammartin, Irène A. Abela et al. · Clinical Infectious Diseases · 2022 · 38 citations · Full text

A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure

Anna Eichenberger, Annina E. Buechi, Andreas Neumayr et al. · BMC Infectious Diseases · 2017 · 31 citations · Full text

Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

Frédérique Chammartin, Katharina Kusejko, Chloé Pasin et al. · AIDS · 2022 · 16 citations · Full text

Causes of death and associated factors over a decade of follow-up in a cohort of people living with HIV in rural Tanzania

Getrud Joseph Mollel, Lilian Moshi, Hoda Hazem et al. · BMC Infectious Diseases · 2022 · 15 citations · Full text

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®

Benjamin Speich, Frédérique Chammartin, Daniel C. Smith et al. · Trials · 2021 · 12 citations · Full text